The second and final installment of our discussion focuses on the use of stem cells and what further research is on the horizons for multiple sclerosis.
Browsing: emerging therapies
Ask the Experts: Emerging therapies in multiple sclerosis (Part I: mechanisms, therapies and challenges)
In the first installment of this discussion, our experts discuss the mechanisms, therapies and challenges involved in multiple sclerosis research.
In this editorial from Biomarkers in Medicine, discover how axonal transporter proteins may be utilized as biomarkers for a variety of neurological disorders.
Using transcranial direct current stimulation to treat symptoms in mild cognitive impairment and Alzheimer’s disease
Discover how transcranial stimulation may be used as a therapy for cognitive impairment and Alzheimer’s disease in this review article from Neurodegenerative Disease Management
Alzheimer’s Society give us a round-up of their dementia research highlights from 2017.
Discover the emerging field of biomaterials in regenerative strategies for spinal cord injury in this editorial Future Science OA.
Cell therapies administered in the chronic phase after stroke: a meta-analysis examining safety and efficacy
Preliminary findings suggest that some cell therapies may be relatively safe and effective, but larger double-blinded placebo-controlled studies are needed to establish the long-term risks and benefits.
This article discusses two potential neural networks, the serotonergic system and the OTergic system, that could prove to be particularly useful targets for endocrine therapy.
Researchers have demonstrated that the enzymatic activity of R5 receptor-type protein tyrosine phosphatases is a requisite for the maintenance of stem cell properties and tumorigenicity in glioblastoma cells and could be a promising drug target for treatment.
Researchers have identified a novel mechanism by which cells die in Alzheimer’s disease, which my aid future therapies targeting cell loss in the brain.